BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 19180404)

  • 1. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany].
    Pruszydlo MG; Quinzler R; Kaltschmidt J; Haefeli WE
    Dtsch Med Wochenschr; 2008 Jul; 133(27):1423-8. PubMed ID: 18592450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tablet splitting: do discount contracts influence prescribing quality?].
    Quinzler R; Bertsche T; Szecsenyi J; Haefeli WE
    Med Klin (Munich); 2008 Aug; 103(8):569-74. PubMed ID: 18807231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implementation of "aut idem" before and after introduction of rebate contracts].
    Hoffmann F; Windt R; Glaeske G
    Dtsch Med Wochenschr; 2010 Apr; 135(15):739-44. PubMed ID: 20373270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prescription of generic drugs in general practice. Results of a survey of general practitioners].
    Simmenroth-Nayda A; Hummers-Pradier E; Ledig T; Jansen R; Niebling W; Bjerre LM; Kochen MM; Himmel W
    Med Klin (Munich); 2006 Sep; 101(9):705-10. PubMed ID: 16977394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in drug prescribing under the Public Health Reform Law--a survey of general practitioners' attitudes in East and West Germany.
    Himmel W; Kron M; Thies-Zajonc S; Kochen MM
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):164-9. PubMed ID: 9112138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side-effects of generic.
    Ruzić K; Medved P; Dadić-Hero E; Graovac M; Tatalović-Vorkapić S; Grzeta IR
    Psychiatr Danub; 2010 Mar; 22(1):99-101. PubMed ID: 20305600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' opinions and experiences of the Pharmaceutical Benefits Reform.
    Andersson K; Jörgensen T; Carlsten A
    Scand J Public Health; 2006; 34(6):654-9. PubMed ID: 17132599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany--socioeconomic aspects in hepatitis C].
    Niederau C; Bemba G; Kautz A
    Z Gastroenterol; 2006 Apr; 44(4):305-17. PubMed ID: 16625459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Information on medications - How do chronically ill patients assess counselling on drugs in general practice?].
    Mahler C; Jank S; Hermann K; Haefeli WE; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Aug; 134(33):1620-4. PubMed ID: 19650022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General practitioners' views on generic medication and substitution.
    Tilyard MW; Dovey SM; Rosenstreich D
    N Z Med J; 1990 Jul; 103(893):318-20. PubMed ID: 2371006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of insurance-driven medication changes on patient care.
    Rood MN; Cruz-Knight W; Cunagin J; Zyzanski SJ; Werner JJ; Mason MJ; Lawson PJ; Stange KC; Flocke SA
    J Fam Pract; 2012 Jul; 61(7):E1-7. PubMed ID: 22754895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient knowledge about drugs prescribed at primary healthcare facilities.
    Akici A; Kalaça S; Uğurlu MU; Toklu HZ; Iskender E; Oktay S
    Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):871-6. PubMed ID: 15455466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
    Jünger C; Rathmann W; Giani G
    Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New cost saving legislation for drugs. National health insurance carriers do not want to believe Ulla Schmidt}].
    MMW Fortschr Med; 2006 Feb; 148(5):45. PubMed ID: 16518939
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-related medication underuse: do patients with chronic illnesses tell their doctors?
    Piette JD; Heisler M; Wagner TH
    Arch Intern Med; 2004 Sep; 164(16):1749-55. PubMed ID: 15364667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.